| Mount Sinai Beth Israel | |
| First Avenue At 16th Street, New York, New York 10003 | |
| (212) 420-2000 | |
| Name | Mount Sinai Beth Israel |
|---|---|
| Type | Acute Care Hospital |
| Location | First Avenue At 16th Street, New York, New York |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | Yes |
| Medicare ID (CCN) | 330169 |
| NPI Number | 1134585953 |
| Organization Name | MOUNT SINAI BETH ISRAEL |
| Address | 10 Nathan D Perlman Pl, 3s21b, New York, NY 10003 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-420-3969 |
News Archive
News outlets also report on how other changes are affecting small business owners, hospitals and students.
Shionogi & Co., Ltd. and QuatRx Pharmaceuticals Company, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator ("SERM").
A qualitative study led by researchers at the Johns Hopkins Bloomberg School of Public Health yielded nine patient-driven recommendations across circumstances that include changes to insurance, supportive services and financial assistance to reduce long-term, breast cancer-related economic burden.
A large international study has discovered a strong link between infant exposure to paracetamol and the development of asthma and other allergic conditions such as eczema.
› Verified 2 days ago
| NPI Number | 1588067813 |
| Organization Name | MOUNT SINAI BETH ISRAEL |
| Address | 317 E 17th St Ste 2f05, New York, NY 10003 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-420-2885 |
News Archive
News outlets also report on how other changes are affecting small business owners, hospitals and students.
Shionogi & Co., Ltd. and QuatRx Pharmaceuticals Company, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator ("SERM").
A qualitative study led by researchers at the Johns Hopkins Bloomberg School of Public Health yielded nine patient-driven recommendations across circumstances that include changes to insurance, supportive services and financial assistance to reduce long-term, breast cancer-related economic burden.
A large international study has discovered a strong link between infant exposure to paracetamol and the development of asthma and other allergic conditions such as eczema.
› Verified 2 days ago
| NPI Number | 1588813646 |
| Organization Name | BETH ISRAEL MEDICAL CENTER |
| Address | 281 1st Ave, New York, NY 10003 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 347-495-4982 |
News Archive
News outlets also report on how other changes are affecting small business owners, hospitals and students.
Shionogi & Co., Ltd. and QuatRx Pharmaceuticals Company, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator ("SERM").
A qualitative study led by researchers at the Johns Hopkins Bloomberg School of Public Health yielded nine patient-driven recommendations across circumstances that include changes to insurance, supportive services and financial assistance to reduce long-term, breast cancer-related economic burden.
A large international study has discovered a strong link between infant exposure to paracetamol and the development of asthma and other allergic conditions such as eczema.
› Verified 2 days ago
| NPI Number | 1790947091 |
| Organization Name | BETH ISRAEL MEDICAL CENTER |
| Address | 16 E 16th St, New York, NY 10003 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-420-2000 |
News Archive
News outlets also report on how other changes are affecting small business owners, hospitals and students.
Shionogi & Co., Ltd. and QuatRx Pharmaceuticals Company, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator ("SERM").
A qualitative study led by researchers at the Johns Hopkins Bloomberg School of Public Health yielded nine patient-driven recommendations across circumstances that include changes to insurance, supportive services and financial assistance to reduce long-term, breast cancer-related economic burden.
A large international study has discovered a strong link between infant exposure to paracetamol and the development of asthma and other allergic conditions such as eczema.
› Verified 2 days ago
| NPI Number | 1851666408 |
| Organization Name | BETH ISRAEL MEDICAL CENTER |
| Address | 281 1st Ave, New York, NY 10003 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-420-2000 |
News Archive
News outlets also report on how other changes are affecting small business owners, hospitals and students.
Shionogi & Co., Ltd. and QuatRx Pharmaceuticals Company, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator ("SERM").
A qualitative study led by researchers at the Johns Hopkins Bloomberg School of Public Health yielded nine patient-driven recommendations across circumstances that include changes to insurance, supportive services and financial assistance to reduce long-term, breast cancer-related economic burden.
A large international study has discovered a strong link between infant exposure to paracetamol and the development of asthma and other allergic conditions such as eczema.
› Verified 2 days ago
| NPI Number | 1992916878 |
| Organization Name | BETH ISRAEL MEDICAL CENTER |
| Address | 16th Street First Avenue, New York, NY 10003 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-420-2000 |
News Archive
News outlets also report on how other changes are affecting small business owners, hospitals and students.
Shionogi & Co., Ltd. and QuatRx Pharmaceuticals Company, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator ("SERM").
A qualitative study led by researchers at the Johns Hopkins Bloomberg School of Public Health yielded nine patient-driven recommendations across circumstances that include changes to insurance, supportive services and financial assistance to reduce long-term, breast cancer-related economic burden.
A large international study has discovered a strong link between infant exposure to paracetamol and the development of asthma and other allergic conditions such as eczema.
› Verified 2 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
News outlets also report on how other changes are affecting small business owners, hospitals and students.
Shionogi & Co., Ltd. and QuatRx Pharmaceuticals Company, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator ("SERM").
A qualitative study led by researchers at the Johns Hopkins Bloomberg School of Public Health yielded nine patient-driven recommendations across circumstances that include changes to insurance, supportive services and financial assistance to reduce long-term, breast cancer-related economic burden.
A large international study has discovered a strong link between infant exposure to paracetamol and the development of asthma and other allergic conditions such as eczema.
› Verified 2 days ago
Mount Sinai Hospital Acute Care Hospital Location: One Gustave L Levy Place, New York, New York 10029 Phone: (212) 241-7981 | |
Mount Sinai St Luke's Roosevelt Hospital Acute Care Hospital Location: 1000 Tenth Avenue, New York, New York 10019 Phone: (212) 523-4000 | |
Ny Eye And Ear Infirmary Of Mount Sinai Acute Care Hospital Location: 230 Second Ave, New York, New York 10003 Phone: (212) 979-4000 | |
New York-presbyterian Hospital Acute Care Hospital Location: 525 East 68th Street, New York, New York 10065 Phone: (212) 746-5454 | |
Lenox Hill Hospital Acute Care Hospital Location: 100 East 77th Street, New York, New York 10021 Phone: (212) 439-2345 | |
Mount Sinai Beth Israel Acute Care Hospital Location: First Avenue At 16th Street, New York, New York 10003 Phone: (212) 420-2000 |